Clinical trials
Observational Breast Neoplasms trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Unknown status | 12 |
| Recruiting | 9 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hacettepe University | 6 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 5 |
| Izmir Bakircay University | 5 |
| Atlas University | 4 |
| Gazi University | 3 |
| Istanbul Training and Research Hospital | 3 |
| Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 3 |
| Antalya Training and Research Hospital | 2 |
| AstraZeneca | 2 |
| Federation of Breast Diseases Societies | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 74 |
| Lymphedema | 8 |
| Postoperative Pain | 8 |
| Breast Cancer Lymphedema | 5 |
| Chronic Pain | 4 |
| Neoplasms | 4 |
| Cardiotoxicity | 3 |
| Agnosia | 2 |
| Colonic Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.